University of Illinois at Chicago researchers using functional MRI found the dorsolateral prefrontal cortex region of the brain is less active in patients with pediatric bipolar disorder and attention deficit hyperactivity disorder than in controls.
University of Illinois at Chicago researchers using functional MRI found the dorsolateral prefrontal cortex region of the brain is less active in patients with pediatric bipolar disorder and attention deficit hyperactivity disorder than in controls. The prefrontal cortex controls behavior such as impulsivity, executive function, and cognitive processes such as working memory, attention, and language.
The researchers imaged children aged 10 to 18 with fMRI as they performed a working memory task. Subjects with bipolar disorder exhibited greater deployment of the emotion-processing circuitry and reduced deployment of working memory circuitry compared with healthy subjects. Commonalities with attention deficit hyperactivity disorder included corticosubcortical activity that was reduced under negative emotional challenge and increased under positive emotional challenge (J Am Acad Child Adolesc Psychiatry 2010;49:1064-1080).
The goal of the research is to develop imaging markers of behavioral illness that can be used in a clinical setting, the authors said.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.